---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-007739"
form_type: "8-K"
ticker: "TECH"
cik: "0000842023"
company_name: "BIO-TECHNE Corp"
filed_at: "2023-05-03T23:59:59+00:00"
generated_at: "2026-06-16T02:05:46.018196+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "low"
source: SEC EDGAR
---

# Bio-Techne reports Q3 fiscal 2023 results and declares cash dividend; specific figures not available

## Summary
- Press release for quarter ended March 31, 2023 issued May 3, 2023.
- Dividend announcement made same day with no per-share amount disclosed in filing.
- No financial figures, guidance, or YoY comparisons provided in the 8-K body.

## SEC filing metadata
- accession: 0001558370-23-007739
- form_type: 8-K
- ticker: TECH
- cik: 0000842023
- company_name: BIO-TECHNE Corp
- filed_at: 2023-05-03T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: low
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/842023/000155837023007739/0001558370-23-007739-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/842023/000155837023007739/tmb-20230503x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-007739
- JSON: https://secwatch.observer/filing/0001558370-23-007739.json
- Plain text: https://secwatch.observer/filing/0001558370-23-007739.txt

## Key facts
- Earnings Releases
  BIO-TECHNE Corp reported financial results for the quarter ended March 31, 2023.
  - Period: the quarter ended March 31, 2023
  - Result: reported results
  source text: A copy of the press release issued by Bio-Techne Corporation on May 3, 2023, describing the results of operations for the quarter ended March 31, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/842023/000155837023007739/0001558370-23-007739-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.